Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOL-DP-o-04 in Low Back Pain and Sciatica
NCT04145310Phase 2Completed
- Sponsor
- BOL Pharma
- Start
- Nov 2018
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BOL-DP-o-04 in low back pain (LBP) and Sciatica (2 arms), sponsored by BOL Pharma. Primary endpoint: Oswestry Disability Index. Started Nov 2018; status: completed.
02
Drugs
BOL-DP-o-04
03
Conditions
low back pain (LBP)Sciatica
Beyond the preview
Go deeper on NCT04145310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145310.